ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 168

$766K Total Retail Price of All Prescriptions

Rank: 6 out of 168

573 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 573 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

12% of this provider’s 573 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 7,991 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $114 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 473 410 1 2
AMLODIPINE BESYLATE 323 269 2 1
SIMVASTATIN 290 250 3 8
LISINOPRIL 267 213 4 3
METOPROLOL SUCCINATE 254 182 5 16
HYDROCODONE-ACETAMINOPHEN 253 161 S3 6 18
HYDROCHLOROTHIAZIDE 245 210 7 20
LEVOTHYROXINE SODIUM 238 165 8 15
ATORVASTATIN CALCIUM 210 181 9 19
LOSARTAN POTASSIUM 203 142 10 10
OMEPRAZOLE 199 125 11 12
POTASSIUM CHLORIDE 195 176 12 30
JANUVIA 179 155 13 46
METOPROLOL TARTRATE 179 142 13 7
GABAPENTIN 169 122 15 26
LANTUS 162 118 16 37
INSULIN SYRINGE 160 123 17 42
CARVEDILOL 152 110 18 11
GLIPIZIDE 145 136 19 45
CRESTOR 140 93 20 41
TERAZOSIN HCL 128 106 21 60
WARFARIN SODIUM 126 101 22 31
ZOLPIDEM TARTRATE 126 73 22 40
ALLOPURINOL 122 111 24 13
ROPINIROLE HCL 115 83 25 71
SPIRONOLACTONE 111 96 26 25
METFORMIN HCL 109 84 27 29
PRAVASTATIN SODIUM 109 77 27 27
BUMETANIDE 101 100 29 34
CLONIDINE HCL 101 42 29 9
CALCITRIOL 97 65 31 6
PANTOPRAZOLE SODIUM 96 76 32 39
TRAMADOL HCL 96 84 32 35
ATENOLOL 96 91 32 38
HUMULIN N 93 51 35 66
PREDNISONE 88 50 36 23
RENVELA 88 14 36 4
RANITIDINE HCL 84 42 38 51
TRAZODONE HCL 71 19 39 81
OXYCODONE HCL 69 37 S2 40 83
MIDODRINE HCL 68 34 41 75
DOXAZOSIN MESYLATE 68 50 41 21
FAMOTIDINE 67 61 43 57
METOCLOPRAMIDE HCL 67 29 43 70
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 45 45 82
CYMBALTA 64 48 46 90
FINASTERIDE 64 60 46 61
ISOSORBIDE MONONITRATE ER 64 60 46 50
NIFEDIPINE ER 64 21 46 28
ZETIA 63 62 50 68
TORSEMIDE 61 57 51 58
GLIPIZIDE ER 61 50 51 77
HUMULIN 70-30 58 51 53 118
SENSIPAR 54 11 54 5
LIPITOR 53 47 55 103
FENOFIBRATE 53 39 55 117
SERTRALINE HCL 52 21 57 52
VENLAFAXINE HCL ER 52 12 57 172
HUMULIN R 51 40 59 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.